Manus Neurodynamica is backed by Par Equity, angel investors with a focus on high growth; Scottish Investment Bank, the investment arm of Scotland’s main economic development agency; Old College Capital, the venture capital arm of The University of Edinburgh; and individual investors including members of the board.
Together these investors provided seed capital in a funding round in 2018.
Par Equity
Par Equity is a venture capital investor focused on businesses with global ambitions, and innovative technology at their core. Since 2009 it has made 40 investments in a wide variety of growth companies and has achieved a number of profitable exits.
Par Equity’s model integrates the insights and experiences of industry insiders into every facet of the investment process and, because these people are investors, their interests are closely aligned with Par Equity’s managed venture funds. The investor network also provides a pool of individuals who can work with entrepreneurs to help them overcome the challenges that are frequently encountered in building high-growth companies.
Old College Capital
Old College Capital LP (OCC) is the in house venture capital fund of the University of Edinburgh. The Fund was established in 2011 with support from the University and its Endowment Fund. The objective of the Fund is to provide growth and development finance into early and mid-stage spin-out and start-up companies as part of syndicated venture capital rounds.
OCC follows a formal investment process and the Investment Committee makes the decision for OCC to invest or not. The Committee has highly experienced and respected individuals drawn from the University and the financial services industry.
Scottish Investment Bank
The Scottish Investment Bank (SIB) is the investment arm of Scottish Enterprise working in partnership with Highlands and Islands Enterprise.
SIB supports economic growth by increasing the supply of finance to Scottish businesses, and helping companies to identify appropriate sources of finance, engage with funders and secure the investment they need to grow their business, as well as helping them strengthen their management teams, make connections and accelerate growth.
SIB operates a number of equity funds on a shared risk co-investment basis with UK and international investors, including business angels, angel syndicates, venture capital groups and corporate investors.
Where equity investment is provided Scottish Enterprise becomes a shareholder in the business.
Craig L. Burr
Mr. Craig L. Burr serves as an Advisor at Woodhaven Capital Partners. He is Limited Partner at J. Devien Capital, LLC, Johns Creek Partners, LLC, The Zucker Group, Channelstone Capital Partners, LLC, Longreach Capital, LLC and Blue Horizon Capital, LLC. Mr. Burr is employed at Blackford Capital, LLC. Mr. Burr served as an Advisor at Agilis Equity Partners LLC. He was the Founder and Managing Director at Burr, Egan, Deleage & Co. He founded the Burr, Egan, Deleage & Co
Investment enquiry
We would welcome opportunities to discuss our business plan with potential investors.
Investors
So funktioniert der NeuroMotor Stift
Unsere disruptive Technologie kann in verschiedenen Anwendungsbereichen genutzt werden, wie Screening, Triage, Diagnose, Medikations-Optimierung, Arzneimittel-Entwicklung, Pflege und Grundlagenforschung. Alle Bereiche helfen unser Verständnis von neuromotorischen Beeinträchtigungen zu verbessern! Wir suchen die Zusammenarbeit mit interessierten Forschern, Ärzten und Mitarbeitern des Gesundheitswesens, um unser Verständnis der Problematik zu vertiefen und schlussendlich die Leistungsfähigkeit unserer Produkte zu verbessern.